Literature DB >> 20345759

Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades.

Hu-Nan Sun1, Sun-Uk Kim, Song Mei Huang, Jin-Man Kim, Young-Ho Park, Seok-Ho Kim, Hee-Young Yang, Kyoung-Jin Chung, Tae-Hoon Lee, Hoon Sung Choi, Ju Sik Min, Moon-Ki Park, Sang-Keun Kim, Sang-Rae Lee, Kyu-Tae Chang, Sang-Ho Lee, Dae-Yeul Yu, Dong-Seok Lee.   

Abstract

Reactive oxygen species (ROS) actively participate in microglia-mediated pathogenesis as pro-inflammatory molecules. However, little is known about the involvement of specific antioxidants in maintaining the microglial oxidative balance. We demonstrate that microglial peroxiredoxin (Prx) 5 expression is up-regulated by lipopolysaccharide (LPS) through activation of the ROS-sensitive signaling pathway and is involved in attenuation of both microglial activation and nitric oxide (NO) generation. Unlike in stimulation of oxidative insults with paraquat and hydrogen peroxide, Prx V expression is highly sensitive to LPS-stimulation in microglia. Reduction of ROS level by treatment with either NADPH oxidase inhibitor or antioxidant ablates LPS-mediated Prx V up-regulation in BV-2 microglial cells and is closely associated with the activation of the c-jun N-terminal kinase (JNK) signaling pathway. This suggests the involvement of ROS/JNK signaling in LPS-mediated Prx V induction. Furthermore, NO induces Prx V up-regulation that is ablated by the addition of inducible nitric oxide synthase inhibitor or deleted mutation of inducible nitric oxide synthase in LPS-stimulated microglia. Therefore, these results suggest that Prx V is induced by cooperative action among the ROS, RNS, and JNK signaling cascades. Interestingly, knockdown of Prx V expression causes the acceleration of microglia activation, including augmented ROS generation and JNK-dependent NO production. In summary, we demonstrate that Prx V plays a key role in the microglial activation process through modulation of the balance between ROS/NO generation and the corresponding JNK cascade activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345759     DOI: 10.1111/j.1471-4159.2010.06691.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Morphological changes and altered expression of antioxidant proteins in a heterozygous dynein mutant; a mouse model of spinal muscular atrophy.

Authors:  Larisa M Wiggins
Journal:  Oxid Antioxid Med Sci       Date:  2014

2.  Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway.

Authors:  M D Shahaduzzaman; Vijay Mehta; Jason E Golden; Derrick D Rowe; Suzanne Green; Ramya Tadinada; Elspeth A Foran; Paul R Sanberg; Keith R Pennypacker; Alison E Willing
Journal:  Cell Transplant       Date:  2015-02-26       Impact factor: 4.064

3.  Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.

Authors:  Y-H Park; S-U Kim; T-H Kwon; J-M Kim; I-S Song; H-J Shin; B-K Lee; D-H Bang; S-J Lee; D-S Lee; K-T Chang; B-Y Kim; D-Y Yu
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

4.  Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.

Authors:  Young-Ho Park; Sun-Uk Kim; Bo-Kyoung Lee; Hyun-Sun Kim; In-Sung Song; Hye-Jun Shin; Ying-Hao Han; Kyu-Tae Chang; Jin-Man Kim; Dong-Seok Lee; Yeul-Hong Kim; Chang-Min Choi; Bo-Yeon Kim; Dae-Yeul Yu
Journal:  Antioxid Redox Signal       Date:  2013-06-13       Impact factor: 8.401

5.  CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation.

Authors:  James M Kennedy; Nassima Fodil; Sabrina Torre; Silayuv E Bongfen; Jean-Frédéric Olivier; Vicki Leung; David Langlais; Charles Meunier; Joanne Berghout; Pinky Langat; Jeremy Schwartzentruber; Jacek Majewski; Mark Lathrop; Silvia M Vidal; Philippe Gros
Journal:  J Exp Med       Date:  2014-11-17       Impact factor: 14.307

6.  Peroxiredoxin 5 Protects TGF-β Induced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells.

Authors:  Hoon-In Choi; Seong Kwon Ma; Eun Hui Bae; JongUn Lee; Soo Wan Kim
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 7.  Overview on Peroxiredoxin.

Authors:  Sue Goo Rhee
Journal:  Mol Cells       Date:  2016-01       Impact factor: 5.034

8.  Clinical relevance of thyroid cell models in redox research.

Authors:  Francesca Cammarota; Francesco Fiscardi; Tiziana Esposito; Gabriella de Vita; Marco Salvatore; Mikko O Laukkanen
Journal:  Cancer Cell Int       Date:  2015-12-09       Impact factor: 5.722

9.  2-cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone inhibits LPS-induced BV2 microglial activation through MAPK/NF-kB signaling pathways.

Authors:  Hu-Nan Sun; Gui-Nan Shen; Yong-Zhe Jin; Yu Jin; Ying-Hao Han; Li Feng; Lei Liu; Mei-Hua Jin; Ying-Hua Luo; Tea-Ho Kwon; Yu-Dong Cui; Cheng-Hao Jin
Journal:  Heliyon       Date:  2016-07-20

Review 10.  Multiple Roles of Peroxiredoxins in Inflammation.

Authors:  Bernard Knoops; Vasiliki Argyropoulou; Sarah Becker; Laura Ferté; Oksana Kuznetsova
Journal:  Mol Cells       Date:  2016-01-25       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.